Pereira Brian JG 4

4 · PROKIDNEY CORP. · Filed Feb 6, 2025

Form 4

Period: 2025-02-04

Director

Transactions

Conversion
Class A Ordinary Shares
2025-02-04+81,928→ 81,928 total
Conversion
Common Units in ProKidney LP
2025-02-04−81,928→ 81,929 total
Exercise: $0.00→ Class A Ordinary Shares (81,928 underlying)
Conversion
Class A Ordinary Shares
2025-02-04+675,234→ 675,234 total(indirect: By Trust)
Conversion
Common Units in ProKidney LP
2025-02-04−675,234→ 675,235 total(indirect: By Trust)
Exercise: $0.00→ Class A Ordinary Shares (675,234 underlying)
Conversion
Class B Ordinary Shares
2025-02-04−81,928→ 81,929 total
Exercise: $0.00→ Class A Ordinary Shares (81,928 underlying)
Conversion
Class B Ordinary Shares
2025-02-04−675,234→ 675,235 total(indirect: By Trust)
Exercise: $0.00→ Class A Ordinary Shares (675,234 underlying)

Footnotes (3)

[F1]The Class B Ordinary Shares and the Common Units in ProKidney LP (a "Common Unit") are paired securities. At the election of the reporting person and subject to the limitations set forth in the Exchange Agreement and the Second Amended and Restated Company Partnership Agreement (each filed as an Issuer's Annual Report on Form 10-K filed on March 22, 2024), each Class B Ordinary Share, together with a paired Common Unit, may be exchanged for Class A Ordinary Shares on a one-for-one basis.
[F2]The Class B Ordinary Shares were received pursuant to the terms of the Business Combination Agreement by and between the Issuer and ProKidney LP, dated as of January 18, 2022 (the "Business Combination Agreement"), in exchange for historical interests held by the reporting person in ProKidney LP. The Class B Ordinary Shares do not expire.
[F3]The Common Units were received pursuant to the terms of the Business Combination Agreement in exchange for historical interests held by the reporting person in ProKidney LP. The Common Units do not expire.

Documents

1 file